Search research articles
Contact Us
Filters
Showing results (111-120 of 120) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 120 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 1998
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease
G Tissingh, J Booij, P Bergmans, et al.
Experimental Brain Research
|
January 1, 1991
Localization of dopamine and its relation to the growth hormone producing cells in the central nervous system of the snail Lymnaea stagnalis
T R Werkman, J van Minnen, P Voorn, et al.
Neuroendocrinology
|
January 1, 1982
Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review
T E Cote, R L Eskay, E A Frey, et al.
Journal of Neuroscience Research
|
March 1, 1992
Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone
C H Langeveld, M P van Waas, J C Stoof, et al.
Synapse (New York, N.Y.)
|
August 25, 1999
Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain
L Reneman, J Booij, J Lavalaye, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1997
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease
J Booij, G Tissingh, G J Boer, et al.
Synapse (New York, N.Y.)
|
June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys
R J Vermeulen, B Drukarch, N P Verhoeff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 26, 1998
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease
J Booij, J B Habraken, P Bergmans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2001
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients
A Winogrodzka, R C Wagenaar, P Bergmans, et al.
Nuclear Medicine and Biology
|
November 1, 1995
Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease
R J Vermeulen, E C Wolters, G Tissingh, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 120) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 120 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 1998
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease
G Tissingh, J Booij, P Bergmans, et al.
Experimental Brain Research
|
January 1, 1991
Localization of dopamine and its relation to the growth hormone producing cells in the central nervous system of the snail Lymnaea stagnalis
T R Werkman, J van Minnen, P Voorn, et al.
Neuroendocrinology
|
January 1, 1982
Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review
T E Cote, R L Eskay, E A Frey, et al.
Journal of Neuroscience Research
|
March 1, 1992
Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone
C H Langeveld, M P van Waas, J C Stoof, et al.
Synapse (New York, N.Y.)
|
August 25, 1999
Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain
L Reneman, J Booij, J Lavalaye, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 1, 1997
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease
J Booij, G Tissingh, G J Boer, et al.
Synapse (New York, N.Y.)
|
June 1, 1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys
R J Vermeulen, B Drukarch, N P Verhoeff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 26, 1998
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease
J Booij, J B Habraken, P Bergmans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 19, 2001
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients
A Winogrodzka, R C Wagenaar, P Bergmans, et al.
Nuclear Medicine and Biology
|
November 1, 1995
Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease
R J Vermeulen, E C Wolters, G Tissingh, et al.
Page
of 12